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Hypersensitivity reactions to aspirin (acetylsalicylic acid-
ASA) and other nonsteroidal anti-inflammatory drugs
(NSAIDs) constitute only a subset of all adverse reactions
to these drugs, but due to their severity they pose a signifi-
cant risk to patients. The authors report a case of a 48
year old woman with asthma, hypertension, obstructive
sleep apnea and a NSAIDs-exacerbated respiratory disease:
hypersensitivity reactions induced by aspirin and metami-
zol manifesting primarily as bronchial obstruction and
dyspnea. She was regulary medicated with budesonide
400mg 2x/day, ipratropium bromide dry powder inhaler
once a day, montelukast 10mg/day, bilastine 20mg/day
and terbutaline. The patient had a giant fusiform aneur-
ysm with carotid-cavernous sinus partially thrombosed in
a subacute phase. For endovascular treatment of aneur-
ysm, the patient need a stent placement in the left internal
carotid artery under antiplatelet therapy with ASA. The
patient was referred to our Department and was submitted
to a desensitization protocol in an emergence context due
to the risk of aneurism rupture. At the time, her asthma
was not controlled so it was necessary to carry out medi-
cation with bronchodilators and oral corticosteroids while
doing the procedure. The protocol followed this sequence:
on the first day 5, 10, 25, 50, 75, 100 and 250mg of ASA
were administered at intervals of 30 minutes. On the
second day the patient performed one single dose of
500mg, without reactions. After surgery, she remained on
100mg of ASA daily without reaction. The authors sought
to adapt a safe and practical protocol to allow the adminis-
tration of ASA to patients with a NSAIDs-exacerbated
respiratory disease. In live-saving situations is very
important to reflect, reevaluate the indications and contra-
indications for desensitization. Note that it is possible to
make a successful desensitization even in a patient with
uncontrolled asthma.
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